TY - JOUR
T1 - Conduction slowing by the gap junctional uncoupler carbenoxolone
AU - de Groot, Joris R.
AU - Veenstra, Thijs
AU - Verkerk, Arie O.
AU - Wilders, Ronald
AU - Smits, Jeroen P. P.
AU - Wilms-Schopman, Francien J. G.
AU - Wiegerinck, Rob F.
AU - Bourier, Jan
AU - Belterman, Charly N. W.
AU - Coronel, Ruben
AU - Verheijck, E. Etienne
PY - 2003
Y1 - 2003
N2 - Background: Cellular electrical coupling is essential for normal propagation of the cardiac action potential, whereas reduced electrical coupling is associated with arrhythrmas. Known cellular uncoupling agents have severe side effects on membrane ionic currents. We investigated the effect of carbenoxolone on cellular electrical coupling, membrane ionic currents, and atrial and ventricular conduction. Methods and Results: In isolated rabbit left ventricular and right atrial myocytes, carbenoxolone (50 mumol/l) had no effect on action potential characteristics. Calcium, potassium, and sodium currents remained unchanged. Dual current clamp experiments on poorly coupled cell pairs revealed a 21 +/- 3% decrease in coupling conductance by carbenoxolone (mean +/- S.E.M., n = 4, p <0.05). High-density activation mapping was performed in intact rabbit atrium and ventricle during Langendorff perfusion of the heart. The amplitude of the Laplacian of the electrograms, a measure of coupling current in intact hearts, decreased from 1.45 +/- 0.66 to 0.75 +/- 0.51 muA/mm(3) (mean +/- SD, n = 32, p <0.05) after 15 min of carbenoxolone. Carbenoxolone reversibly decreased longitudinal and transversal conduction velocity from 66 +/- 15 to 49 +/- 16 cm/s and from 50 +/- 14 to 35 +/- 15 cm/s in ventricle, respectively (mean SD, n = 5, both p <0.05). In atrium, longitudinal and transversal conduction, velocity decreased from 80 +/- 29 to 60 +/-16 cm/s and from 49 +/- 10 to 38 +/- 10 cm/s (mean SD, n = 8, both p <0.05). Conclusions: Carbenoxolone-induced uncoupling causes atrial and ventricular conduction slowing without affecting cardiac membrane currents. Activation delay is larger in poorly coupled cells. (C) 2003 European Society of Cardiology. Published by Elsevier B.V. All rights reserved
AB - Background: Cellular electrical coupling is essential for normal propagation of the cardiac action potential, whereas reduced electrical coupling is associated with arrhythrmas. Known cellular uncoupling agents have severe side effects on membrane ionic currents. We investigated the effect of carbenoxolone on cellular electrical coupling, membrane ionic currents, and atrial and ventricular conduction. Methods and Results: In isolated rabbit left ventricular and right atrial myocytes, carbenoxolone (50 mumol/l) had no effect on action potential characteristics. Calcium, potassium, and sodium currents remained unchanged. Dual current clamp experiments on poorly coupled cell pairs revealed a 21 +/- 3% decrease in coupling conductance by carbenoxolone (mean +/- S.E.M., n = 4, p <0.05). High-density activation mapping was performed in intact rabbit atrium and ventricle during Langendorff perfusion of the heart. The amplitude of the Laplacian of the electrograms, a measure of coupling current in intact hearts, decreased from 1.45 +/- 0.66 to 0.75 +/- 0.51 muA/mm(3) (mean +/- SD, n = 32, p <0.05) after 15 min of carbenoxolone. Carbenoxolone reversibly decreased longitudinal and transversal conduction velocity from 66 +/- 15 to 49 +/- 16 cm/s and from 50 +/- 14 to 35 +/- 15 cm/s in ventricle, respectively (mean SD, n = 5, both p <0.05). In atrium, longitudinal and transversal conduction, velocity decreased from 80 +/- 29 to 60 +/-16 cm/s and from 49 +/- 10 to 38 +/- 10 cm/s (mean SD, n = 8, both p <0.05). Conclusions: Carbenoxolone-induced uncoupling causes atrial and ventricular conduction slowing without affecting cardiac membrane currents. Activation delay is larger in poorly coupled cells. (C) 2003 European Society of Cardiology. Published by Elsevier B.V. All rights reserved
U2 - https://doi.org/10.1016/j.cardiores.2003.07.004
DO - https://doi.org/10.1016/j.cardiores.2003.07.004
M3 - Article
C2 - 14613858
SN - 0008-6363
VL - 60
SP - 288
EP - 297
JO - Cardiovascular research
JF - Cardiovascular research
IS - 2
ER -